Psomagen served as a sequencing partner for the CZI-funded Billion Cells Project.
Public source
Publisher name
Public post
Excited to share this groundbreaking work from Alex Marson and his team at Gladstone/UCSF, now published in Cell Press! Their genome-scale Perturb-seq maps of human T ce…
Company
Psomagen
CLIA/CAP-Accredited Multiomic Services Partner
- Industry
- Biotechnology Research
- Location
- Rockville, US
- Company size
- 51–200 employees
About Psomagen
Psomagen, Inc., formerly Macrogen Corp, delivers genomic sequencing services to the clinical, academic, and consumer markets. Psomagen’s labs are US-based and CLIA and CAP certified. Not only is the company accredited to perform the highest quality Sanger sequencing, Next-Generation Sequencing and Microarray Gene Analysis, it is also networked with Macrogen’s worldwide headquarters, stretching its capabilities and capacity across a diverse set of labs around the world. Learn more at psomagen.com.
See moreLatest activity
Latest activity from Psomagen
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
Novogene Europe
Novogene Europe became a member of the Oxford Nanopore Technologies Service Provider Programme.
Partnerships
AD-Omics
AD-Omics is supporting the newly announced UK Pre-clinical Translational Models Hub as a technical partner.
Partnerships
Flomics
Flomics has officially signed a collaboration agreement with M20 Genomics as an authorized service provider for single-cell sequencing across Southern Europe.
Products & Services
Complete Genomics
Complete Genomics and the Center for Microbiome Innovation at UC San Diego are making high-resolution spatial transcriptomics more accessible with the Stereo-seq service promotion.
Partnerships
M20 Genomics